medigraphic.com
Boletín Médico del Hospital Infantil de México

2008, Number 6

<< Back Next >>

Bol Med Hosp Infant Mex 2008; 65 (6)

Present role of surgical treatment. Can surgery cure metabolic diseases?

López F, Herrera MF

Language: Spanish
References: 34
Page: 568-578
PDF size: 179.51 Kb.


ABSTRACT

There has been a dramatic increase in the prevalence of obesity worldwide in both children and adults. It is well known that obesity leads to an increased risk of complications such as type 2 diabetes and the metabolic syndrome. The prevalence of this syndrome in the obese population of children is 4.2% and it increases up to 50% in morbidly obese adolescents. Bariatric surgery has shown a long lasting excess weight loss of 75%, and a positive impact in the resolution or improvement of many metabolic syndrome parameters. Type 2 diabetes is controlled in 72 to 76% of patients after surgery and it has been recognized that improvement occurs even before a significant weight loss is achieved. An effect on the entero-insular axis has been proposed as a mechanism for metabolic control. Based on the dramatic impact of bariatric surgery on the metabolic syndrome, some authors have proposed to perform bariatric surgery in patients with type 2 diabetes and a BMI ‹35 kg/m2. Indications for bariatric surgery have been extended to adolescents and some specific guidelines have been developed.


REFERENCES

  1. Rossi M, Barretto-Ferreira da Silva R, Chaves-Alcântara Jr G, et al. Remission of metabolic syndrome: A study of 140 patients six months after Roux-en-Y gastric bypass. Obes Surg. 2008; 18: 601-6.

  2. Marcos-Daccarett NJ, Núñez-Rocha GM, Salinas-Martínez AM, Santos-Ayarzagoitia M, Decanini-Arcaute H. Obesidad como factor de riesgo para trastornos metabólicos en adolescentes mexicanos, 2005. Rev Salud Publica. 2007; 9: 180-93.

  3. Menchaca-Martín P, Zonana-Nacach A. Obesidad en niños mexicanos de la frontera norte. [Cartas al editor]. Salud Publica Mex. 2006; 48: 1.

  4. Xanthakos SA, Daniels SR, Inge TH. Bariatric surgery in adolescents: An update. Adolesc Med Clin. 2006; 17: 589-612.

  5. Perichart-Perera O, Balas-Nakash M, Schiffman-Selechnik E, Barbato-Dosal A, Vadillo-Ortega F. Obesity increases metabolic syndrome risk factors in school-aged children from an urban school in Mexico City. J Am Diet Assoc. 2007; 107: 81-91.

  6. Helmrath MA, Brandt ML, Inge TH. Adolescent obesity and bariatric surgery. Surg Clin North Am. 2006; 86: 441-54.

  7. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004; 350: 2362-74.

  8. Folli F, Pontiroli AE, Schwesinger WH. Metabolic aspects of bariatric surgery. Med Clin North Am. 2007; 91: 393-414.

  9. Kini S, Herron DM, Yanagisawa RT. Bariatric surgery for morbid obesity - a cure for metabolic syndrome? Med Clin North Am. 2007; 91: 1255-71.

  10. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004; 240: 416-24.

  11. Buchwald H. Consensus Conference Panel. Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. J Am Coll Surg. 2005; 200: 593-604.

  12. Brolin RE, LaMarca LB, Kenler HA, Cody RP. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg. 2002; 6: 195-205.

  13. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002; 346: 1623-30.

  14. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292: 1724-37.

  15. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004; 351: 2683-93.

  16. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357: 741-52.

  17. Nguyen NT, Lee SL, Goldman C, et al. Comparison of pulmonary function and postoperative pain after laparoscopic versus open gastric bypass: a randomized trial. J Am Coll Surg. 2001; 192: 469-77.

  18. Scopinaro N, Papadia F, Marinari G, Camerini G, Adami G. Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI <35 kg/m2. Obes Surg. 2007; 17: 185-92.

  19. DePaula AL, Macedo AL, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008; 22: 706-16.

  20. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222: 339-52.

  21. Cummings S, Apovian CM, Khaodhiar L. Obesity surgery: Evidence for diabetes prevention/management. J Am Diet Assoc. 2008; 108 (4 Suppl 1): S40-4.

  22. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006; 55: 2025-31.

  23. Rubino F, Gagner M, Gentileschi P, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004; 240: 236-42.

  24. Kushner RF, Noble CA. Long-term outcome of bariatric surgery: an interim analysis. Mayo Clin Proc. 2006; 81 (10 Suppl): S46-51.

  25. Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007; 17: 176-84.

  26. Wolf AM, Beisiegel U. The effect of loss of excess weight on the metabolic risk factors after bariatric surgery in morbidly and super-obese patients. Obes Surg. 2007; 17: 910-9.

  27. Perry CD, Hutter MM, Smith DB, Newhouse JP, McNeil BJ. Survival and changes in comorbidities after bariatric surgery. Ann Surg. 2008; 247: 21-7.

  28. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: Surgical treatment of obesity. Ann Intern Med. 2005; 142: 547-59.

  29. Dixon JB, O’Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg. 2002; 184: 51S-4S.

  30. Carvalho PS, Moreira CL, Barelli Mda C, et al. Can bariatric surgery cure metabolic syndrome? Arq Bras Endocrinol Metabol. 2007; 51: 79-85.

  31. Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P. A pilot study of long-term effects of a novel obesity treatment: Omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord. 2002; 26: 193-9.

  32. Patriti A, Facchiano E, Annetti C, et al. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg. 2005; 15: 1258-64.

  33. Cohen R, Pinheiro JS, Correa JL, Schiavon CA. Laparoscopic Roux-en-Y gastric bypass for BMI <35 kg/m2): a tailored approach. Surg Obes Relat Dis. 2006; 2: 401-4.

  34. Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: Concerns and recommendations. Pediatrics. 2004; 114: 217-23.




2020     |     www.medigraphic.com